Menu
Recruiting NCT05343130

Efficacy of a Brain-Computer Interface Controlled Functional Electrical Stimulation Therapy for Spinal Cord Injury Neurorehabilitation

No phase Interventional Cervical Spinal Cord Injury

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Brain-Computer Interface, Sham Brain-Computer Interface.
Who it may be relevant to
Registry conditions: Cervical Spinal Cord Injury. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Mexico
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Efficacy of a Therapy With Brain-Computer Interface Controlled Functional Electrical Stimulation for Neurorehabilitation of Patients With Spinal Cord Injury (Eficacia de Una Terapia Con estimulación eléctrica Funcional Controlada Con Interfaz Cerebro-computadora Para neurorrehabilitación de Pacientes Con lesión Medular)

Overview

The study's main goal is to determine the efficacy of a therapy with brain-computer interface controlled functional electrical stimulation for neurorehabilitation of spinal cord injury patients' upper limbs. For this purpose, a randomized controlled trial will be performed to compare the clinical and physiological effects of the brain-computer interface therapy with those of a sham intervention comprised by the application of functional electrical stimulation independently of brain-computer interface control.

Interventions

  • Device Brain-Computer Interface
    Hand movement will be elicited using functional electrical stimulation activated by the brain-computer interface based on hand movement intention.
  • Device Sham Brain-Computer Interface
    Hand movement will be elicited using functional electrical stimulation which activation will be independent of the brain-computer interface based on hand movement intention.

Primary outcome measures

  • Action Research Arm Test (ARAT) [Time frame: At enrollment and after 7 weeks of the intervention onset]
  • Upper Extremity Motor Score (UEMS) [Time frame: At enrollment and after 7 weeks of the intervention onset]
  • Capabilities of Upper Extremities Questionnaire (CUE-Q) [Time frame: At enrollment and after 7 weeks of the intervention onset]
Secondary outcome measures (2)
  • Spinal Cord Independence Measure III (SCIM-III) [Time frame: At enrollment and after 7 weeks of the intervention onset]
  • Life Satisfaction Questionnaire 9 (LISAT-9) [Time frame: At enrollment and after 7 weeks of the intervention onset]

Eligibility criteria

Inclusion criteria

  • Spinal Cord Injury at neurological levels C6 or C7
  • American Spinal Injury Association (ASIA) classification A, B, C or D
  • Upper limb spasticity of less or equal to +1 measured with the Modified Ashworth Scale
  • Time since disease onset of more than 6 months and less than 60 months
  • Normal or corrected to normal vision

Exclusion criteria

  • Severe attention deficits
  • Previous diagnosis of traumatic brain injury
  • Previous diagnosis of peripheral nerve injury
  • Previous stroke diagnosis
  • Previous diagnosis of neurodegenerative diseases
  • History of fractures in upper extremities
  • Skin lesions
  • Contractures in upper extremities that hamper mobility
  • Excessive muscle spasms

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Mexico · 1 center
  • Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra (National Institute of R — Tlalpan

Identifiers

NCT: NCT05343130 · 10/22

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗